Aberrant p53 overexpression in benign colon biopsies may predict dysplasia risk in patients with primary sclerosing cholangitis and inflammatory bowel disease
{{output}}
Aims: Patients with primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD), collectively termed PSC-IBD, have an increased risk of developing nonconventional and/or invisible colorectal dysplasia, particularly ... ...
